Skip to content

Flexible Ureteroscopy With and Without Ureteral Access Sheath in Treatment of Large Renal Stones

Flexible Ureteroscopy With and Without Ureteral Access Sheath in Treatment of Large Renal Stones: a Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06122129
Enrollment
84
Registered
2023-11-08
Start date
2023-11-08
Completion date
2024-03-20
Last updated
2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flexible Ureteroscopy, Large Renal Stones, Ureteral Access Sheath

Brief summary

The aim of this study is to evaluate the flexible ureteroscope (FURS) technique with and without ureteral access sheath (UAS).

Detailed description

Treating a large renal stone, more than 2 cm, is changing during the last decades. Technological innovations have led to a significant improvement in flexible ureteroscopes over recent years. Many authors have used flexible ureteroscope (FURS) with laser fragmentation as proved treating modality with high efficacy. Although percutaneous extraction of large renal stones is still the first option, it has higher and more severer complications than flexible ureteroscopy. FURS has developed into a standard diagnostic and treatment modality for upper urinary stone disease, transitional cell carcinoma and ureteral strictures. Indeed, more recently FURS is becoming a minimally invasive competitor to percutaneous nephrolithotomy for larger kidney stones as well as an accepted modality for localized treatment of small upper urinary tract transitional cell carcinoma. The use of ureteral access sheath (UAS) is widely recognized as a technique utilized to keep the intrarenal pressure low when performing FURS for larger and more complex stones, although some authors advocate its use for most renal stones. UASs are now produced with varying characteristics including various lengths, diameters, materials, dilator tip designs, radiopaque markers, and stiffness. However, it also rises surgical costs and may injure the ureteral wall. Most common reasons cited by urologists for using a UAS are to facilitate repeated entrance into the ureter and collecting system (as a time-saver), lower intrarenal pressure and protection of ureteroscope and ureter when extracting stone fragments. UAS has encouraged urologists in the fragmentation of large stones; it facilitates multiple entries and stone extraction during FURS.

Interventions

PROCEDUREFlexible ureteroscope with ureteral access sheath

The flexible ureteroscope either directly or via an access sheath, depending on the size of the ureter, a 9.5/11.5 Fr or a 12 Fr access sheath will be used.

PROCEDUREFlexible ureteroscope without ureteral access sheath

Ureteroscopy will be carried out without a ureteral access sheath

Sponsors

New Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old. * Both sexes. * Patients with upper ureter and renal stones scheduled for flexible ureteroscope.

Exclusion criteria

* Patients with associated distal ureteral stone, kidney transplant or any kind of urinary diversion. * Larger stones (11 cm) where the routine use of an access sheath will be felt appropriate to aid multiple passes of the scope. * Known ureteric strictures. * Concomitant ureteric stones. * Patients with narrow ureter where ureteral access sheath was anticipated to be difficult.

Design outcomes

Primary

MeasureTime frameDescription
Operative timeIntraperativelyTime from sterilization till the end of surgery

Secondary

MeasureTime frameDescription
Stone-free rate28 days after interventionStone-free status was defined as no residual stones or residual stones with a maximum diameter ≤ 4 mm with no clinical symptoms at 1 month after the procedure
Complications28 days after interventionComplications such as mucosal lacerations, bleeding, urosepsis, and stein Strasse.
Duration of stay28 days after interventionTime from admission till hospital discharge
Number of patients who need ancillary procedures28 days after interventionNeed for Ancillary Procedures if there was residual.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026